Prognostic characteristics in breast cancers after hormone replacement therapy

Breast Cancer Research and Treatment

Volumn 38, Issue 3, 1996, Pages 325-334

  Magnusson, Cecilia ^a   Holmberg, Lars ^a   Nordén, Torgny ^a   Lindgren, Anders ^a   Persson, Ingemar ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast cancer; Estrogen; HRT; Progestin; Prognosis

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRIOL; GESTAGEN; HORMONE RECEPTOR; LEVONORGESTREL;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR VOLUME;

AGED; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PLOIDIES; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; SWEDEN;

EID: 0029918807     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806152     Document Type: Article

References (21)

1. Dupont WD, Page DL: Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 151: 67-72, 1991
2. Steinberg KK, Thacker SB, Smith SJ, Stroup DF, Zack MM, Flanders WD, Berkelman RL: A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 15: 1985-1990, 1991
3. Yuen J, Persson I, Bergkvist L, Hoover R, Schairer C, Adami HO: Hormone replacement therapy and breast cancer mortality in Swedish women. Results after adjustment for 'healthy drug user effect'. Cancer Causes Control 4: 369-374, 1993
4. Hunt K, Vessey M, McPhersson K: Mortality in cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Oh Gyn 97: 1080-1086, 1990
5. Henderson BE, Paganini-Hill A, Ross RK: Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 151: 75-78, 1991
6. Brinton LA, Hoover R, Fraumeni JF Jr: Menopausal estrogens and breast cancer risk: an expanded case-control study. Br J Cancer 54: 825-832, 1986
7. Bergkvist L, Adami HO, Persson I, Bergström R, Krusemo UB: Prognosis after breast cancer diagnosed in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol 130: 221-228, 1989
8. Persson I, Adami HO, Johansson EDB, Lindberg BL, Manell P, Westerholm B: A cohort study of oestrogen treatment and the risk of endometrial cancer: evaluation of method and its applicability. Eur J Clin Pharmacol 25: 625-632, 1983
9. Ackerman LV: Surgical Pathology. CV Mosby, St. Louis, 1968, p 736
10. Auer G, Caspersson T, Wallgren A: DNA content and survival in mammary carcinoma. Annal Quant Cytol 3: 161-165, 1980
11. Strang P: Comparison between flow cytometry and single cell cytophotometry for DNA content analysis of the uterine cervix. Acta Radiol Oncol 24: 337-341, 1985
12. Wrange Ö, Nordenskjöld B, Gustafsson JA°: Cytosol estradiol receptor in human mammary carcinoma: an assay based on isoelectric focusing in polyacrylamide gel. Annal Biochem 85: 461-475, 1978
13. Breslow N, Day N: Statistical Methods in Cancer Research. Vol 1. The analysis of case-control studies. IARC, Lyon, 1980
14. Holmberg L, Adami HO, Ekbom A, Sandström A, Bergström R: Prognostic significance of the Ackerman classification and other histopathological characteristics in breast cancer. An analysis of 1,349 consecutive cases with complete follow up over seven years. APMIS 96: 979-990, 1988
15. Galea MH, Blamey RW, Elston CW, Ellis IO: The Nottingham prognostic index in primary breast cancer. Breast Cancer Res Treat 22: 207-219, 1992
16. Todd JH, Dowle C, Williams MR, Elston CW, Ellis IO, Hinton CP, Blamey RW, Haybittle JL: Confirmation of a prognostic index in primary breast cancer. Br J Cancer 56: 489-492, 1987
17. Crowe J, Gordon N, Shenk R, Zollinger R, Brumberg D, Shuck J: Primary tumour size: relevance to breast cancer survival. Arch Surg 127: 910-916, 1992
18. McGuire WL: Prognostic factors for recurrence and survival in human breast cancer. Breast Cancer Res Treat 10: 5-9, 1987
19. Toikkanen S, Joensuu H, Klemi HP: The prognostic significance of nuclear DNA content in invasive breast cancer - a study with long-term follow-up. Br J Cancer 60: 693-700, 1989
20. Nordén T, Holmberg L, Lindgren A, Bergström R, Adami HO: Hormone receptors, DNA ploidy and prognosis in operable breast cancer patients given no adjuvant treatment. The Breast, in press
21. Colditz GA, Stampfer MJ, Willett WC, Hunter DJ, Manson JE, Hennekkens CH, Rosner BA, Speizer FE: Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study. Cancer Causes Control 3: 433-439, 1992